Quality of reporting of meta-analyses: The QUOROM statement. Will it help?

Journal of Hepatology

Volumn 34, Issue 2, 2001, Pages 342-345

  Christensen, Erik ^a  

^a BISPEBJERG HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL RESEARCH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; EPIDEMIOLOGICAL DATA; HUMAN; LIVER DISEASE; MEDICAL LITERATURE; META ANALYSIS; PRIORITY JOURNAL; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL; REVIEW;

GASTROENTEROLOGY; HUMANS; META-ANALYSIS; PUBLICATION BIAS; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIALS;

EID: 0035117037     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(00)00002-7     Document Type: Review

References (28)

1. Meta-analyses of randomized controlled trials
2. Improving the quality of reporting of randomized controlled trials. The CONSORT statement
3. Improving the quality of reports of meta-analyses of randomized controlled trials: The QUOROM statement
4. Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: Effects of dose and duration
5. Therapy of hepatitis C: Meta-analysis of interferon alfa-2b trials
6. Chronic hepatitis C: Interferon retreatment of relapsers. A meta-analysis of individual patient data. European concerted action on viral hepatitis (EUROHEP)
7. The effect of interferon on the liver in chronic hepatitis C: A quantitative evaluation of histology by meta-analysis
8. Ribavirin enhances the efficacy but not the adverse effects of interferon in chronic hepatitis C. Meta-analysis of individual patient data from European centers
9. Interferon as treatment for acute hepatitis C. A meta-analysis
10. Chronic hepatitis C and interferon alpha: Conventional and cumulative meta-analyses of randomized controlled trials
11. Beta-adrenergic antagonists in the prevention of gastrointestinal rebleeding in patients with cirrhosis: A meta-analysis
12. Transjugular intrahepatlc portosystemic shunt compared with endoscopic treatment for prevention of variceal rebleeding: A meta-analysis
13. Propranolol and sclerotherapy in the prevention of gastrointestinal rebleeding in patients with cirrhosis: A meta-analysis
14. Role of vasoactive drugs in the treatment of bleeding oesophageal varices
15. TIPS for prevention of recurrent bleeding in patients with cirrhosis: Meta-analysis of randomized clinical trials
16. Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: A meta-analysis
17. Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with ascites: A meta-analysis
18. Randomized controlled trials of ursodeoxycholic-acid therapy for primary biliary cirrhosis: A meta-analysis
19. Quality assessment of reports on clinical trials in the Journal of Hepatology
20. Randomized clinical trials in hepatology: Predictors of quality
21. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials
22. Do certain countries produce only positive results? A systematic review of controlled trials
23. European concerted action on viralhepatitis (Eurohep). The treatment effect of alpha interferon in chronic hepatitis B is independent of pre-treatment variables. Results based on individual patient data from 10 clinical controlled trials
24. Interferon treatment in patients with chronic hepatitis B: A meta-analysis of the published literature
25. Why review articles on the health effects of passive smoking reach different conclusions
26. Statistical elements of the randomized clinical trial
27. Glucocorticorticoids are ineffective in alcoholic hepatitis: A meta-analysis adjusting for confounding variables
28. Explaining heterogeneity in meta-analysis: A comparison of methods